TMCnet3d
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
In addition, the Company closed its previously announced concurrent private placement with funds affiliated with Leavitt Equity Partners for the purchase and sale of 267,686 shares of common stock and ...
Le Lézard3d
RingCentral Announces Appointment of Kira Makagon as President and Chief Operating Officer
RingCentral, Inc. , a global leader in AI-powered trusted business communications, today announced that it has appointed Kira Makagon, current Chief Innovation Officer and CMO, as President and Chief ...
Allurion to sell 900,000 shares at $5.23 in registered direct offering
Allurion Technologies (ALUR) announced that it has entered into a definitive securities purchase agreement with certain institutional investors ...
Le Lézard5d
U.S. FDA Accepts Gilead's New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir?the company's twice-yearly injectable HIV ...
Allurion Technologies to initiate Allurion Balloon with GLP-1 agonists study
Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...